Bringing the Oncology Community Together

Talimogene laherparepvec significantly improved durable response rates but failed to extend overall survival in patients with advanced melanoma.
The FDA has approved ofatumumab plus chlorambucil for previously untreated patients with chronic lymphocytic leukemia who are considered inappropriate for treatment with fludarabine therapy.
Judith A. Salerno, MD, MS, president, CEO, Susan G. Komen, discusses access to care for patients with breast cancer.
David F. Penson, MD, MPH, director, Center for Surgical Quality and Outcomes Research Professor of Urologic Surgery, Paul V. Hamilton, M.D. and Virginia E. Howd Chair in Urologic Oncology, professor of medicine, Vanderbilt University Medical Center, discusses some of the advantages and disadvantages of a large urologic practice.
Oliver Sartor, MD, board professor, cancer research, Tulane University, discusses the distinction between symptomatic and asymptomatic patients with bone metastases from prostate cancer.
Oliver Sartor, MD, board professor, cancer research, Tulane University, discusses the distinction between symptomatic and asymptomatic patients with bone metastases from prostate cancer.
Among physicians, oncologists fall slightly above the middle in terms of compensation, with average earnings reported at $290,000.
William G. Wierda, MD, PhD, professor, Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, discusses treatment options for patients with CLL who harbor the 17p deletion.
Issue List
    Most Popular Right Now
    External Resources

    American Journal of Managed Care
    HCPLive
    PainLive
    Pharmacy Times
    Physicians' Education Resource
    Physician's Money Digest
    Specialty Pharmacy Times
    TargetedOnc
    OncLive Resources

    Archives
    Blogs
    OncLive TV
    Oncology Nurses
    Publications
    Specialties
    Web Exclusives


    About Us
    Advertise
    Advisory Board
    Contact Us
    Forgot Password
    Privacy Policy
    Terms & Conditions
    Intellisphere, LLC
    666 Plainsboro Road
    Building 300
    Plainsboro, NJ 08536
    P: 609-716-7777
    F: 609-716-4747

    Copyright OncLive 2006-2014
    Intellisphere, LLC. All Rights Reserved.